Tilray | TRLY - Eps Gewinn Pro Aktie

Aktienkurs
8.54
Täglich Wechseln
-0.58 -6.36%
Monatlich
-17.57%
Jährlich
818.28%
Q1 Prognose
8.33




Eps Veränderung Datum
Acasti Pharma USD -0.06 0.15 2025-09
Akebia Therapeutics USD -0.04 0.04 2025-12
Alaunos Therapeutics USD -0.53 0.08 2025-09
Aurora Cannabis CAD -0.64 0.36 2025-12
Avita Medical AUD -0.38 0 2025-12
Canopy Growth CAD -0.05 0.03 2025-12
Cronos Group USD 0.02 0.05 2025-12
Dianthus Therapeutics USD -1.43 0.46 2025-12
Divis Laboratories Ltd INR 21.98 3.99 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
IQVIA Holdings USD 3.42 0.42 2025-12
Knight Therapeutics CAD -0.09 0.12 2025-12
Moderna USD -2.11 1.6 2025-12
Organigram Holdings CAD -0.16 0.02 2025-12
Organon & Co USD 0.63 0.38 2025-12
Revvity USD 1.7 0.52 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Tilray USD -0.41 0.4 2025-12
Viatris USD 0.57 0.1 2025-12
Xeris Pharmaceuticals USD 0.05 0.05 2025-12
Zealand Pharma A/S -8.34 2.6 2025-12